Designing Novel Anticancer Drug Leads Based on the Natural Products Gracilin A and Pateamine A
dc.contributor.advisor | Romo, Daniel | |
dc.contributor.author | Jones, Dalton | |
dc.contributor.department | Biology. | en_US |
dc.date.accessioned | 2021-05-20T16:31:13Z | |
dc.date.available | 2021-05-20T16:31:13Z | |
dc.date.copyright | 2021 | |
dc.date.issued | 2021-05-20 | |
dc.description.abstract | Natural products form the foundation of many different small molecules used as drugs. Molecular modeling is a key tool in the early stages of drug development that helps to identify derivatives of natural products that might be promising drug leads. This thesis uses molecular modeling and computational studies to explore the potential of natural products gracilin A and pateamine A as the foundation of future anticancer drug leads. I first explore the role of specific target proteins in the body with a focus on cancer cells, then analyze the binding sites of the target proteins in a three-dimensional space with a focus on their compatibility with the natural products. Finally, I perform a series of docking simulations to identify promising compounds for future synthesis and testing in biological assays. | en_US |
dc.identifier.uri | https://hdl.handle.net/2104/11285 | |
dc.language.iso | en_US | en_US |
dc.rights | Baylor University projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission. | en_US |
dc.rights.accessrights | Worldwide access. | en_US |
dc.rights.accessrights | Access changed 9/21/23. | |
dc.title | Designing Novel Anticancer Drug Leads Based on the Natural Products Gracilin A and Pateamine A | en_US |
dc.type | Thesis | en_US |
Files
Original bundle
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.87 KB
- Format:
- Item-specific license agreed upon to submission
- Description: